Details for New Drug Application (NDA): 018760

✉ Email this page to a colleague

NDA 018760 describes TENORETIC 50, which is a drug marketed by Twi Pharms and is included in one NDA. It is available from one supplier. Additional details are available on the TENORETIC 50 profile page.

The generic ingredient in TENORETIC 50 is atenolol; chlorthalidone. There are thirty-four drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the atenolol; chlorthalidone profile page.

Summary for 018760

Tradename:	TENORETIC 50
Applicant:	Twi Pharms
Ingredient:	atenolol; chlorthalidone
Patents:	0

Pharmacology for NDA: 018760

Mechanism of Action	Adrenergic beta-Antagonists
Physiological Effect	Increased Diuresis

Suppliers and Packaging for NDA: 018760

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
TENORETIC 100	atenolol; chlorthalidone	TABLET;ORAL	018760	NDA	Upsher-Smith Laboratories, LLC	24979-256	24979-256-07	90 TABLET in 1 BOTTLE (24979-256-07)
TENORETIC 100	atenolol; chlorthalidone	TABLET;ORAL	018760	NDA	Upsher-Smith Laboratories, LLC	24979-257	24979-257-07	90 TABLET in 1 BOTTLE (24979-257-07)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	100MG;25MG
Approval Date:	Jun 8, 1984	TE:	AB	RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	50MG;25MG
Approval Date:	Jun 8, 1984	TE:	AB	RLD:	Yes

Expired US Patents for NDA 018760

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Twi Pharms	TENORETIC 100	atenolol; chlorthalidone	TABLET;ORAL	018760-001	Jun 8, 1984	3,663,607	⤷ Get Started Free
Twi Pharms	TENORETIC 50	atenolol; chlorthalidone	TABLET;ORAL	018760-002	Jun 8, 1984	3,934,032	⤷ Get Started Free
Twi Pharms	TENORETIC 50	atenolol; chlorthalidone	TABLET;ORAL	018760-002	Jun 8, 1984	3,663,607	⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.